NSE: INDRAMEDCO · BSE: 532150 · ISIN INE681B01017
Indraprastha Medical Corporation Limited stock analysis
Indraprastha Medical Corporation Limited ranks #897 in the TickerSutra evidence-ranked universe with a score of 59/100 and 95% data confidence. The latest captured fundamentals show ROCE of 35.8%, quarterly sales growth of 11.3% and quarterly profit growth of 8.5%.Monitor only
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- ROCE is 35.8%
- Low debt/equity of 0.05×
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- No calculated threshold risk in the current snapshot.
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹888cr | ₹120cr | ₹59cr | 14.0% |
| 2023 | ₹1,099cr | ₹152cr | ₹86cr | 14.0% |
| 2024 | ₹1,245cr | ₹195cr | ₹124cr | 16.0% |
| 2025 | ₹1,356cr | ₹245cr | ₹161cr | 18.0% |
| 2026 | ₹1,483cr | ₹267cr | ₹184cr | 18.0% |
| TTM | ₹1,524cr | ₹274cr | ₹188cr | 18.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
Indraprastha Medical Corporation Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results.
RoutineIndraprastha Medical Corporation Ltd - 532150 - AGM On 24Th September, 2026-Voting Results And Consolidated Report Of SrutinizerBSE · 25 Sept 2026The 38th AGM of the company was held on 24th September, 2026 through VC and OAVM and the buisness mentioned in the notice dated 6th August, 2026 was transacted. Enclosed please find the ....
RoutineIndraprastha Medical Corporation Ltd - 532150 - Closure of Trading WindowNSE · 22 Sept 2026 · Structured filingThe Trading Window for dealing in shares of the Company shall remain closed for all designated persons including Promoters, Directors, KMPs and other Designated Employee and their connected ....
The Trading Window for dealing in shares of the Company shall remain closed for all designated persons including Promoters, Directors, KMPs and other Designated Employee and their connected ....
Open original XBRL sourceMANAGEMENT COMMENTARY
Signals from filed documents
OUTLOOK Indraprastha Apollo Hospitals continues to deliver on its commitment to high-quality, sustainable healthcare while accelerating growth across its key service lines. As we move through Financial Year 2026, the Hospital remains focused on strengthening its market leadership through clinical excellence, innovation, and operational ef/f_iciency. Recognised as one of India’s leading integrated healthcare providers
Rising Investments in the Indian Healthcare space: The Indian healthcare sector continues to attract strong investor interest, supported by structural demand growth, cost competitiveness and an evolving policy environment. Continued investments are supporting capacity expansion, technology adoption and service diversi/f_ication across the healthcare ecosystem. The Indian hospital sector in FY27 is expected to witness
Indraprastha Apollo Hospitals also advanced its efforts in water conservation, waste management, and environmentally responsible healthcare delivery. Water recycling initiatives, Zero Liquid Discharge facilities and 100% wastewater treatment continued to support responsible water stewardship, while robust biomedical waste anagement practices ensured regulatory compliance and safe disposal. The Company further leverag
The goal is to reduce the cost of expensive drugs and medical consumables such as stents, implants, and other surgical materials by standardising across the network, optimising procurement costs, consolidating suppliers, and optimising use of medical consumables by establishing guidelines for medical procedures. These measures are critical for driving margin expansion, particularly in the context of rising input cost
They are obligated to guarantee that these transactions do not interfere with their duties and responsibilities to the Company. This policy requires pre-approval from the Audit Committee for such transactions. PRINCIPLE 2: Businesses should provide goods and services in a manner that is sustainable and safe Essential Indicators 1.
At the same time, the sector remains exposed to regulatory, competitive and operational challenges which require continuous monitoring and mitigation. Threats 01 02 03 04 Regulatory Environment Availability of Skilled Healthcare Professionals Cost Pressures & Capital Intensity Competitive Landscape • Pricing controls and reimbursement restrictions • Evolving compliance requirements • Shortage of skilled healthcare pr
MEANS OF COMMUNICATION a) Quarterly Results: Quarterly Results of the Company are published in Financial Express -All Editions and Jansatta (Hindi) – Delhi Edition and are displayed on the Company’s website apollohospitals.com /Delhi b) Of/f_icial News Releases: The Company’s website also displays of/f_icial news releases. c) Presentations made to Institutional Investors or to the Analysts: No presentation was made t
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…